Global Ganja Report

President Donlad Trump on April 18 signed an executive order calling on the DEA and FDA to open legal pathways for research into the therapeutic benefits of certain Schedule I psychedelic drugs—prominently including ibogaine, with an emphasis on its potential to treat PTSD in military veterans. The order instructs the FDA to collaborate with the Department of Veterans Affairs and the private sector "to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies." 

Bob Weir, who helped define the sound of the Grateful Dead, flagship band of the 1960s San Francisco scene, died Jan. 10 at the age of 78. His life was synonymous with the Dead, which he saw through its various incarnations—from its early roots in the Bay Area folk revival and bluegrass circuit to preeminent symbol of the youth counterculture, to an American institution and grand-daddies of the "jam band" tradition.

US air-strikes on so-called "drug boats" have now destroyed 30 vessels and killed more than 100 people in the Caribbean and eastern Pacific. And on Dec. 26, President Donald Trump boasted in a radio interview that the United States had knocked out "a big facility"—implying that it was a drug-trafficking hub on the Venezuelan mainland, although he provided no details and neither the White House, Pentagon nor US intelligence agencies would comment.

President Donald Trump signed an executive order Dec. 18 to accelerate the reclassification of marijuana, a move that would ease decades-old restrictions that have classified the drug alongside heroin as having no accepted medical value.

The US Controlled Substances Act ranks drugs along a five-tier spectrum based on their potential for abuse and recognized medical value. Schedule I drugs are those with a high likelihood of abuse, no accepted medical use, and considerable health risks even when administered under medical supervision. Since 1970, marijuana has been listed alongside heroin as a Schedule I drug. Schedule V drugs are those with accepted medical uses and a relatively low likelihood of abuse.

The US Supreme Court announced Dec. 15 that it will not hear a case challenging the federal illegality of marijuana. The case, Canna Provisions v. Bondi, was brought by four Massachusetts commercial cannabis growers. The businesses alleged that the Controlled Substances Act exceeds the powers of Congress under the Commerce Clause and violates the right to due process under the Fifth Amendment.

It was federal subsidies for healthcare that were center-stage in the government shutdown and the Capitol Hill deal that finally ended it. But the fight over the heretofore ambiguous legal status of hemp-derived THC was also at issue in the end—and this could represent a serious blow to America’s farmers.

In response to the growing tensions between the Trump White House and Colombia, the South American nation's President Gustavo Petro called for replacing the policy of marijuana prohibition with a regulatory framework allowing for adult use and international export of cannabis, like "any good."

The Supreme Court announced Oct. 20 that it will consider whether a federal law prohibiting gun possession by unlawful drug users violates the Second Amendment, marking the latest firearms dispute to reach the high court following its landmark 2022 ruling that significantly expanded gun rights.